Search by Drug Name or NDC
NDC 00031-8692-13 Childrens Robitussin Nighttime Cough Long-Acting DM 2; 15 mg/10mL; mg/10mL Details
Childrens Robitussin Nighttime Cough Long-Acting DM 2; 15 mg/10mL; mg/10mL
Childrens Robitussin Nighttime Cough Long-Acting DM is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE.
MedlinePlus Drug Summary
Chlorpheniramine relieves red, itchy, watery eyes; sneezing; itchy nose or throat; and runny nose caused by allergies, hay fever, and the common cold. Chlorpheniramine helps control the symptoms of cold or allergies but will not treat the cause of the symptoms or speed recovery. Chlorpheniramine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.
Related Packages: 00031-8692-13Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Chlorpheniramine
Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.
Related Packages: 00031-8692-13Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Dextromethorphan
Product Information
| NDC | 00031-8692 |
|---|---|
| Product ID | 0031-8692_7225da3f-32a7-4aa6-9e3e-0cd0dfbe4e53 |
| Associated GPIs | 43995702100915 |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Childrens Robitussin Nighttime Cough Long-Acting DM |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | chlorpheniramine maleate, dextromethorphan hydrobromide |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 2; 15 |
| Active Ingredient Units | mg/10mL; mg/10mL |
| Substance Name | CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE |
| Labeler Name | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| Pharmaceutical Class | Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00031-8692-13 (00031869213)
| NDC Package Code | 0031-8692-13 |
|---|---|
| Billing NDC | 00031869213 |
| Package | 1 BOTTLE in 1 CARTON (0031-8692-13) / 118 mL in 1 BOTTLE |
| Marketing Start Date | 2014-07-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |